Key result
At 6 months after hospitalization for acute heart failure, 28% of patients were alive and well, with new-onset heart failure strongly predicting better health status (OR 2.6).
Why the study?
Recovery of well-being after hospitalisation for acute heart failure reflects treatment success and quality of care, but has rarely been quantified.
Observational (n=4,606)
Yes
Health status recovery after AHF hospitalization is highly variable, with nearly one-third of survivors being 'alive and well' at 6 months, strongly predicted by new-onset HF and higher baseline KCCQ.
AIMS: Recovery of well-being after hospitalisation for acute heart failure (AHF) is a measure of the success of interventions and the quality of care but has rarely been quantified. Accordingly, we measured health status after discharge in an international registry (REPORT-HF) of AHF. METHODS AND RESULTS: The analysis included 4606 patients with AHF who survived to hospital discharge, had known vital status at 6 months, and were enrolled in the United States of America, Russian Federation, or Western Europe, where the Kansas City Cardiomyopathy Questionnaire (KCCQ) was administered. Median age was 69 years (quartiles 59-78), 40% were women, and 34% had a left ventricular ejection fraction (LVEF) <40%, and 12% patients died by 6 months. Of 2475 patients with a follow-up KCCQ, 28% were 'alive and well' (KCCQ >75), while 43% had poor health status (KCCQ ≤50). Being 'alive and well' was associated with new-onset AHF, LVEF <40%, younger age, higher baseline KCCQ, country, and race. Associations were similar for increasing health status, with the exception of country and addition of comorbidities. CONCLUSION: In this international global registry, health status recovery after AHF hospitalisation was highly variable. Those with the best health status at 6 months were younger, had new-onset heart failure, and higher baseline KCCQ; nearly one-third of survivors were 'alive and well'. Investigating reasons for changes in KCCQ after hospitalisation might identify new therapeutic targets to improve patient-centred outcomes.
No takes yet. Share an insight, caveat, or question.
McNaughton et al. (2022) conducted an observational in Acute heart failure (n=4,606). New-onset acute heart failure vs. Acute decompensation of chronic heart failure was evaluated on Alive and well (KCCQ-OSS >75) at 6 months (OR 2.6, 95% CI 2.1-3.4). At 6 months after hospitalization for acute heart failure, 28% of patients were alive and well, with new-onset heart failure strongly predicting better health status (OR 2.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: